SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-035002
Filing Date
2022-06-08
Accepted
2022-06-08 16:05:34
Documents
2
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2251
2 EX-24 DOCUMENT attachment1.htm EX-24 3844
  Complete submission text file 0001209191-22-035002.txt   7434
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 SUMMER STREET SUITE 2300 BOSTON MA 02110
Business Address
Davis Andrew (Reporting) CIK: 0001932525 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34620 | Film No.: 221003525